MELVIN J. PRINCE
MELVIN J. PRINCE publishes mostly in Endocrinology, Diabetes and Metabolism, Surgery and Marketing, on topics such as Diabetes Management and Research, Diabetes Treatment and Management and Diabetes, Cardiovascular Risks, and Lipoproteins.
- World rank
- #269,478 of 7,710,434 ranked researchers
- Rank in United States
- #98,540 of 1,627,098
- Works
- 142
- Citations
- 4.6k
- Citations per work
- 32.4
What does MELVIN J. PRINCE research?
MELVIN J. PRINCE's work is mostly in Medicine (29%), Biochemistry, Genetics and Molecular Biology (10%), Business, Management and Accounting (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else6848.0%
- Health Sciences4128.6%
- Medicine4128.6%
- Social Sciences1913.2%
- Life Sciences1410.2%
- 1Endocrinology, Diabetes and Metabolism22% of their works
- 2Surgery7% of their works
- 3Marketing7% of their works
- 4Sociology and Political Science7% of their works
- 5Molecular Biology6% of their works
- 6Genetics4% of their works
Research topics
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pancreatic function and diabetes
- Metabolism, Diabetes, and Cancer
- Consumer Behavior in Brand Consumption and Identification
- Diabetes and associated disorders
- Digital Marketing and Social Media
Which keywords describe MELVIN J. PRINCE's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Cardiovascular Disease, Diabetes, Type 1 Diabetes, Continuous Glucose Monitoring, Hypoglycemia and Cardiovascular Outcomes.
- Electronic Word-of-Mouth
- Autoimmunity
- Consumer Behavior
- AMP-Activated Protein Kinase
- Pancreatic Islets
- Insulin Resistance
- Cardiovascular Outcomes
- Continuous Glucose Monitoring
- Diabetes
- Insulin Therapy
- Glycemic Control
- Cardiovascular Disease
- Type 1 Diabetes
- Hypoglycemia
- Type 2 Diabetes
- Metabolic Syndrome
- ß-Cell Dysfunction
- Brand Trust
- Metformin
- Genetics
- Social Media
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Glycemic Control492 topics
- Insulin Therapy492 topics
- Cardiovascular Disease432 topics
- Diabetes432 topics
- Type 1 Diabetes352 topics
- Continuous Glucose Monitoring261 topic
- Hypoglycemia261 topic
- Cardiovascular Outcomes231 topic
- Type 2 Diabetes231 topic
- Insulin Resistance171 topic
- Metabolic Syndrome171 topic
- Pancreatic Islets151 topic
- ß-Cell Dysfunction151 topic
- AMP-Activated Protein Kinase141 topic
- Brand Trust141 topic
- Consumer Behavior141 topic
- Metformin141 topic
- Autoimmunity91 topic
- Genetics91 topic
- Electronic Word-of-Mouth81 topic
- Social Media81 topic
Where does MELVIN J. PRINCE work?
MELVIN J. PRINCE's main affiliation in the publication record is Southern Connecticut State University, United States.
How many publications and citations does MELVIN J. PRINCE have?
OpenAlex counts 142 works and 4,595 citations for MELVIN J. PRINCE, an h-index of 38, ranking #269,478 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about MELVIN J. PRINCE. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.